Nebilox


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 21.7%
Product Used For Unknown Indication 20.7%
Drug Use For Unknown Indication 13.0%
Squamous Cell Carcinoma 10.9%
Diabetes Mellitus 6.5%
Atrial Fibrillation 4.3%
Alcoholism 3.3%
Analgesic Intervention Supportive Therapy 3.3%
Dyslipidaemia 3.3%
Hypertension Arterial 3.3%
Arrhythmia Supraventricular 2.2%
Hyperuricaemia 2.2%
Anxiety 1.1%
Coronary Arterial Stent Insertion 1.1%
Deep Vein Thrombosis 1.1%
Escherichia Infection 1.1%
Psychotic Disorder 1.1%
Syncope 16.0%
Renal Failure Acute 12.0%
Vomiting 12.0%
Accommodation Disorder 8.0%
Torsade De Pointes 8.0%
Urinary Retention 8.0%
Hypokalaemia 4.0%
Muscle Rupture 4.0%
Myalgia 4.0%
Nephropathy 4.0%
Persecutory Delusion 4.0%
Renal Impairment 4.0%
Therapeutic Response Unexpected 4.0%
Thrombosis In Device 4.0%
Urinary Tract Infection 4.0%
Concomitant
Product Used For Unknown Indication 23.0%
Hypertension 19.0%
Drug Use For Unknown Indication 17.6%
Type 2 Diabetes Mellitus 4.7%
Depression 4.5%
Bipolar Disorder 3.8%
Atrial Fibrillation 2.9%
Hypercholesterolaemia 2.9%
Diabetes Mellitus 2.7%
Hepatitis C 2.7%
Prophylaxis 2.3%
Breast Cancer 1.8%
Endocarditis 1.8%
Non-small Cell Lung Cancer 1.8%
Psychotic Disorder 1.8%
Pyrexia 1.8%
Hyperglycaemia 1.4%
Cardiac Failure 1.1%
Cerebrovascular Accident 1.1%
Essential Hypertension 1.1%
Hypoglycaemic Coma 8.9%
Coeliac Disease 7.6%
Thrombocytopenia 7.6%
Renal Failure 6.3%
Renal Tubular Necrosis 6.3%
Vomiting 6.3%
Henoch-schonlein Purpura 5.1%
Melaena 5.1%
Sudden Onset Of Sleep 5.1%
Transient Ischaemic Attack 5.1%
Cerebral Haematoma 3.8%
Laryngeal Oedema 3.8%
Nephropathy Toxic 3.8%
Shock 3.8%
Somnolence 3.8%
Suicide Attempt 3.8%
Tendon Disorder 3.8%
Tremor 3.8%
Weight Increased 3.8%
Drug Rash With Eosinophilia And Systemic Symptoms 2.5%

Drug Data